By Peter Bandettini & the OHBM Neurosalience production team
In this week's episode, Peter talks to directly to MRI scanner vendors. Together, they try to reconcile the importance of fMRI in research contexts with the market pressures of developing clinical applications. As fMRI has virtually no clinical market, does it really influence vendor decisions on pulse sequences and hardware? Could more be done aside from making fMRI more clinically relevant? In this discussion, you’ll hear some fascinating history into the early days of echo planar imaging and high speed imaging, as well as insight into the processes by which products are prioritized. You’ll also find out a possible future of how fMRI may begin to become more clinically useful.
R. Scott Hinks, Ph.D. is the Retired Chief Scientist from GE Healthcare's MR division. He received his PhD from the University of Toronto in 1985, where he began his studies of MR Physics and Imaging. For over 34 years Scott has pursued a career in MR research in both industry and academia, specializing in imaging and system physics. He was the principal developer of FSE and has led technical development of EPI for both fMRI and DWI. His work has resulted in numerous publications and over 34 patents. In his most recent role as Chief Scientist for GE Healthcare’s MR division,he is actively engaged in every aspect of MR imaging and works in close collaboration with leading academic researchers worldwide.
Franz Schmitt, Ph.D. is the retired chief scientist from Siemens’ MR division. He received his Ph.D. from the University of Munich and has worked for Siemens since 1983, overseeing development of EPI, gradient and RF coils, both 3T and 7T, as well as pTx imaging. He worked on site at the Martinos Center for a few years in the early 2000’s and has been actively engaged in academic research worldwide.
Ravi Menon, Ph.D. is a Professor of Medical Biophysics, Medical Imaging and Psychiatry at Western University, where he is also a member of the Graduate Program in Neuroscience and the Graduate Program in Biomedical Engineering and Scientific Director of Western’s Centre for Functional and Metabolic Mapping (CFMM), Canada’s only ultra-high field MRI facility. He received his Ph.D. in Medicine from the University of Alberta and performed his post doc in the laboratory of Kamil Ugurbil at the University of Minnesota where he helped to pioneer fMRI.
The Neurosalience production team consists of Rachael Stickland, Kevin Sitek, Katie Moran and Anastasia Brovkin